InsidersTradesSigma
Follow the 迪安诊断 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 迪安诊断 has logged 5 insider filings. Market capitalisation: €12.7bn. The latest transaction was disclosed on 22 July 2026 (Purchase). Among the most active insiders: 陈海斌. The full history is free.
5
Insider Decl.
n/a
Thresholds
€2,965
1 ops.
Buy Volume
€18m
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 迪安诊断 Hold (neutral), based on 6 analysts. Average price target: CN¥19.24.
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,326 of 29,064 companies
43.8
score / 100
Value52
Quality36
FCF yld15%
Earn yld0.4%
EV/EBITDA16.2x
ROE4.5%
Gross mgn28%
Net mgn0.4%
Debt/EBITDA3.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 July 2026
Declarations5 total
5 of 5 declarations
Acerca de 迪安诊断
迪安诊断 es una empresa especializada en servicios de diagnóstico médico en China. Ofrece pruebas de laboratorio y soluciones de salud para mejorar el diagnóstico y tratamiento de enfermedades.